Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Dana P Goldman
Affiliation
University of Southern California
ORCID
Career Start Year
1992
Papers
247
H Index
48
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37234005
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses.
JAMA Netw Open
2023
35801703
The Long-term Value of Bariatric Surgery Interventions for American Adults With Type 2 Diabetes Mellitus.
Ann Surg
2023
37578773
Association of Intensive Lifestyle Intervention for Type 2 Diabetes With Labor Market Outcomes.
JAMA Intern Med
2023
37611204
The Forgotten Middle: Worsening Health And Economic Trends Extend To Americans With Modest Resources Nearing Retirement.
Health Aff (Millwood)
2023
37234005
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses.
JAMA Netw Open
2023
37486673
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.
JAMA
2023
37486673
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.
JAMA
2023
37611204
The Forgotten Middle: Worsening Health And Economic Trends Extend To Americans With Modest Resources Nearing Retirement.
Health Aff (Millwood)
2023
37578773
Association of Intensive Lifestyle Intervention for Type 2 Diabetes With Labor Market Outcomes.
JAMA Intern Med
2023
35801703
The Long-term Value of Bariatric Surgery Interventions for American Adults With Type 2 Diabetes Mellitus.
Ann Surg
2023
34581499
The costs of developing treatments for Alzheimer's disease: A retrospective exploration.
Alzheimers Dement
2022
36062430
Considerations in the implementation of multicancer early detection tests.
Future Oncol
2022
36441791
Association between use of ÿ2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
PLoS One
2022
36252171
Formulary restrictions and stroke risk in patients with atrial fibrillation.
Am J Manag Care
2022
36467603
Effect of COVID-19 vaccine allocation strategies on vaccination refusal: A national survey.
J Risk Res
2022
34581499
The costs of developing treatments for Alzheimer's disease: A retrospective exploration.
Alzheimers Dement
2022
35120691
Complexity Bias in the Prevention of Iatrogenic Injury: Why Specific Harms May Inhibit Performance.
Mayo Clin Proc
2022
36441791
Association between use of ÿ2-adrenergic receptor agonists and incidence of Parkinson's disease: Retrospective cohort analysis.
PLoS One
2022
36467603
Effect of COVID-19 vaccine allocation strategies on vaccination refusal: A national survey.
J Risk Res
2022
36062430
Considerations in the implementation of multicancer early detection tests.
Future Oncol
2022
36252171
Formulary restrictions and stroke risk in patients with atrial fibrillation.
Am J Manag Care
2022
35120691
Complexity Bias in the Prevention of Iatrogenic Injury: Why Specific Harms May Inhibit Performance.
Mayo Clin Proc
2022
32996226
Improved survival for individuals with common chronic conditions in the Medicare population.
Health Econ
2021
34128290
Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context.
Health Econ
2021
33802653
Looking Ahead to 2030: Survey of Evolving Needs in Pharmacy Education.
Pharmacy (Basel)
2021
34228047
Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.
JAMA Neurol
2021
33939503
Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer.
Health Aff (Millwood)
2021
33772966
The future of the elderly population health status: Filling a knowledge gap.
Health Econ
2021
33725260
The economics of alternative payment models for pharmaceuticals.
Eur J Health Econ
2021
33614900
Association between exenatide use and incidence of Alzheimer's disease.
Alzheimers Dement (N Y)
2021
33511897
Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy.
Inquiry
2021
33989095
Modelling the value of innovative treatments for Alzheimer's disease in the United States.
J Med Econ
2021
33716385
Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.
J Econom
2021
33026140
Predicting quantity and quality of life with the Future Elderly Model.
Health Econ
2021
32996226
Improved survival for individuals with common chronic conditions in the Medicare population.
Health Econ
2021
34500239
Opioid-related deaths before and after COVID-19 stay-at-home orders in Los Angeles County.
Drug Alcohol Depend
2021
33716385
Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.
J Econom
2021
33511897
Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy.
Inquiry
2021
33614900
Association between exenatide use and incidence of Alzheimer's disease.
Alzheimers Dement (N Y)
2021
33725260
The economics of alternative payment models for pharmaceuticals.
Eur J Health Econ
2021
33802653
Looking Ahead to 2030: Survey of Evolving Needs in Pharmacy Education.
Pharmacy (Basel)
2021
33772966
The future of the elderly population health status: Filling a knowledge gap.
Health Econ
2021
34500239
Opioid-related deaths before and after COVID-19 stay-at-home orders in Los Angeles County.
Drug Alcohol Depend
2021
33939503
Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer.
Health Aff (Millwood)
2021
34128290
Disparate ageing: The role of education and socioeconomic gradients in future health and disability in an international context.
Health Econ
2021
33989095
Modelling the value of innovative treatments for Alzheimer's disease in the United States.
J Med Econ
2021
34228047
Functional Outcomes Over the First Year After Moderate to Severe Traumatic Brain Injury in the Prospective, Longitudinal TRACK-TBI Study.
JAMA Neurol
2021
33026140
Predicting quantity and quality of life with the Future Elderly Model.
Health Econ
2021
31512180
Trends in Racial and Ethnic Disparities in Diabetes-Related Complications, 1997-2017.
J Gen Intern Med
2020
31804868
Association Between Spending and Outcomes for Patients With Cancer.
J Clin Oncol
2020
1 - 50 of 494
Column Actions
Search
Recommended Authors
Jose F Figueroa
Harvard T.H. Chan School of Public Health
Career Start Year
2016
Number of shared co-authors
2
Stacie B Dusetzina
Vanderbilt University School of Medicine, TN Vanderbilt Ingram Cancer Center
Career Start Year
2009
Number of shared co-authors
0
Suja S Rajan
UTHealth School of Public Health
Career Start Year
2008
Number of shared co-authors
1
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year
2004
Number of shared co-authors
1
Anna D Sinaiko
Harvard T.H. Chan School of Public Health, Harvard University
Career Start Year
2003
Number of shared co-authors
0
Jalpa A Doshi
University of Pennsylvania Perelman School of Medicine
Career Start Year
2002
Number of shared co-authors
0
Nilay D Shah
Mayo Clinic
Career Start Year
2002
Number of shared co-authors
1
Kavita Patel
Brookings Institution - USC Schaeffer Initiative on Health Policy.
Career Start Year
2001
Number of shared co-authors
0
Peter Joski
Rollins School of Public Health, Emory University
Career Start Year
2001
Number of shared co-authors
0
Sanjay Basu
The Pirbright Institute
Career Start Year
2000
Number of shared co-authors
4
John Hsu
Mongan Institute, Massachusetts General Hospital and Harvard Medical School
Career Start Year
1999
Number of shared co-authors
2
Mary Kate Bundorf
Duke University
Career Start Year
1999
Number of shared co-authors
2
Meredith B Rosenthal
Harvard T.H. Chan School of Public Health
Career Start Year
1999
Number of shared co-authors
2
Yong-Fang Kuo
University of Texas Medical Branch at Galveston
Career Start Year
1997
Number of shared co-authors
0
Trudy Millard Krause
School of Public Health, The University of Texas Health Science Center at Houston
Career Start Year
1997
Number of shared co-authors
0
Matthew L Maciejewski
Duke University
Career Start Year
1997
Number of shared co-authors
3
Todd H Wagner
Stanford University School of Medicine
Career Start Year
1996
Number of shared co-authors
1
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Career Start Year
1996
Number of shared co-authors
2
Ellen Meara
Harvard T.H. Chan School of Public Health
Career Start Year
1995
Number of shared co-authors
2
Laurence C Baker
Stanford University
Career Start Year
1993
Number of shared co-authors
4
Andrew J Epstein
University of California san francisco
Career Start Year
1993
Number of shared co-authors
0
Mark S Roberts
School of Public Health, University of Pittsburgh
Career Start Year
1988
Number of shared co-authors
1
Bruce Kinosian
University of Pennsylvania
Career Start Year
1988
Number of shared co-authors
0
David A Asch
University of Pennsylvania, USA Leonard Davis Institute of Health Economics
Career Start Year
1988
Number of shared co-authors
0
Jonathan P Weiner
Johns Hopkins Bloomberg School of Public Health
Career Start Year
1982
Number of shared co-authors
1
Elizabeth A Chrischilles
University of Iowa, School of Public Health
Career Start Year
1982
Number of shared co-authors
0
Endel J Orav
Brigham and Women's Hospital
Career Start Year
1982
Number of shared co-authors
2
Jos?? A Pag??n
New York University
Career Start Year
1981
Number of shared co-authors
0
Stan N Finkelstein
University of Toronto
Career Start Year
1977
Number of shared co-authors
1
Frank A Sloan
Duke University
Career Start Year
1974
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Seth A Seabury
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Co-authored papers
14
??tienne Gaudette
Institute of Health Policy, Dalla Lana School of Public Health, University of Toronto
Co-authored papers
8
Sandra H Berry
Rand Corporation
Co-authored papers
6
Sally C Morton
Virginia Commonwealth University
Co-authored papers
4
Stephen M Shortell
School of Public Health, University of California berkeley
Co-authored papers
3
Alex B Valadka
University of Texas Southwestern Medical Center
Co-authored papers
2
Lindsay D Nelson
Medical College of Wisconsin
Co-authored papers
2
Ross Zafonte
Spaulding Rehabilitation Hospital, Harvard Medical School
Co-authored papers
2
Joseph T Giacino
Spaulding Rehabilitation Hospital
Co-authored papers
2
Gabriela G Satris
University of California san francisco
Co-authored papers
2
Joel H Kramer
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers
2
Ross Bullock
Miller School of Medicine, University of Miami
Co-authored papers
2
Hooshang Kangarloo
university of california los angeles School of Medicine
Co-authored papers
2
Ricky K Taira
University of California los angeles
Co-authored papers
2
Ramon Diaz-Arrastia
University of Pennsylvania
Co-authored papers
2
Kevin K W Wang
Center for Neurotrauma, Morehouse School of Medicine, University of Florida
Co-authored papers
2
Jason N Doctor
University of Southern California
Co-authored papers
2
Esther L Yuh
University of California san francisco
Co-authored papers
2
Neeraj Badjatia
University of Maryland, University of Maryland Medical Center
Co-authored papers
2
Thomas W McAllister
Indiana University School of Medicine
Co-authored papers
2
Geoffrey T Manley
University of California san francisco
Co-authored papers
2
Amy J Markowitz
University of California san francisco
Co-authored papers
2
Christopher J Lindsell
Duke University
Co-authored papers
2
Frederick K Korley
University of Michigan ann arbor
Co-authored papers
2
Daniella Meeker
Schaeffer Center for Health Economics and Policy, University of Southern California
Co-authored papers
2
Nancy Temkin
University of Washington
Co-authored papers
2
Eva M Palacios
University of California san francisco
Co-authored papers
2
Gillian Hotz
University of Miami
Co-authored papers
2
Shankar P Gopinath
Baylor College of Medicine
Co-authored papers
2
David O Okonkwo
University of Pittsburgh Medical Center
Co-authored papers
2
1 - 30